Neumora Therapeutics Inc.... (NMRA)
1.06
-0.04 (-3.64%)
At close: Mar 28, 2025, 2:02 PM
Neumora Therapeutics Common Stock Revenue
Neumora Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2024, Neumora Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
109
Market Cap
171.7M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |